TipRanks on MSN

Larimar Therapeutics Shows Promise in Friedreich’s Ataxia Treatment

Larimar Therapeutics, Inc. ( ($LRMR) ) has released its Q3 earnings. Here is a breakdown of the information Larimar Therapeutics, Inc. presented ...
Stocktwits on MSN

BHVN Stock Tumbled A Whopping 44% Today – What Did The FDA Letter Say?

Biohaven was seeking approval for its drug Vyglxia in the treatment of Spinocerebellar ataxia. ・The company is in the process ...
The Malaysian Reserve

FDA Issues Complete Response Letter for Biohaven’s VYGLXIA (troriluzole) New Drug Application for Spinocerebellar Ataxia

The troriluzole clinical development program encompassed the first industry clinical trials to generate data showing ...